Drug
Pln 101095
Pln 101095: highest development phase Phase 1, developed by Pliant Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pliant Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| PLN-101095 NCT06270706 | Phase 1 | Advanced or Metastatic Solid Tumor |
Latest
No recent events.
Follow Pln 101095 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.